Health Insights Research

 The Neurodegenerative Diseases Drugs Market is experiencing significant growth due to the rising prevalence of neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and spinal muscular atrophy (SMA). These chronic and progressive conditions affect millions globally, leading to cognitive decline, motor dysfunction, and reduced quality of life. The increasing geriatric population, coupled with higher awareness and advancements in diagnostics, is fueling the demand for effective drug therapies. In 2025, the global market was valued at USD 47.86 Billion. With a projected CAGR of 7.10% during 2026–2035, the market is expected to reach USD 95.03 Billion by 2035. The growth is supported by the launch of novel therapies, including disease-modifying drugs, immunomodulators, and advanced dopamine-targeted treatments. Neurodegenerative Diseases Drugs Market Overview Neurodegenerative diseases are characterized by progressive degeneration of the ne...

 The rare haematology disorders market refers to the global industry focused on the treatment, management, and research of uncommon blood disorders. These conditions include rare haemoglobin disorders, platelet disorders, plasma disorders, myeloproliferative disorders, genetic haematology disorders, and rare blood cancers. Due to their low prevalence, these diseases often require specialized treatments, including plasma-derived therapies, recombinant products, and innovative targeted therapies. In 2025, the rare haematology disorders market was valued at USD 1.85 Billion , and it is projected to grow at a CAGR of 10.20% , reaching USD 4.89 Billion by 2035 . This significant growth is driven by the increasing prevalence of rare blood disorders, advancements in biotechnology, and rising adoption of targeted therapies. Rare Haematology Disorders Market Overview Rare haematology disorders present a unique challenge in medical care due to their complex pathophysiology and limited treat...

 The India peritoneal dialysis market is witnessing significant growth due to the increasing prevalence of chronic kidney disease (CKD), rising awareness about home dialysis therapies, and a growing elderly population. Peritoneal dialysis (PD) is a preferred treatment option for patients with end-stage renal disease (ESRD) who require long-term dialysis but prefer flexibility and home-based care. Unlike hemodialysis, PD allows patients to manage treatment at home, reducing hospital visits and improving quality of life. In 2025, the India peritoneal dialysis market was valued at USD 1.09 billion . The market is expected to grow at a CAGR of 9.10% during 2026–2035, reaching USD 2.60 billion by 2035. Factors such as increasing adoption of automated peritoneal dialysis (APD), expansion of home healthcare services, and rising government initiatives for kidney disease management are contributing to market growth. India Peritoneal Dialysis Market Overview Peritoneal dialysis is a renal re...

 The United States Heart Valve Devices Market is experiencing robust growth due to rapid technological advancements, rising prevalence of cardiovascular diseases, and a steadily aging population. Heart valve disorders such as aortic stenosis and mitral regurgitation are becoming increasingly common, particularly among elderly patients, creating sustained demand for both surgical and minimally invasive valve interventions. In 2025, the United States heart valve devices market was valued at USD 3.93 Billion and is expected to grow at a CAGR of 9.60% between 2026 and 2035 , reaching approximately USD 9.83 Billion by 2035 . The shift toward minimally invasive procedures, expanding adoption of transcatheter technologies, and favorable reimbursement policies are reshaping the competitive landscape. In parallel, innovation in biomaterials, imaging guidance, and device durability is improving patient outcomes and expanding the eligible treatment population. United States Heart Valve Devi...

 The Auto-Immune Diseases Market is experiencing steady expansion due to the rising prevalence of autoimmune disorders, improved disease awareness, and significant advancements in diagnostic and therapeutic technologies. Autoimmune diseases occur when the immune system mistakenly attacks healthy cells, leading to chronic and often debilitating conditions. As the global burden of diseases such as rheumatoid arthritis, psoriasis, lupus, multiple sclerosis, and inflammatory bowel disease continues to rise, the demand for effective and long-term treatment options is accelerating. In 2025, the auto-immune diseases market was valued at USD 133.30 Billion and is expected to grow at a CAGR of 4.20%, reaching USD 201.14 Billion by 2035. This growth is supported by increasing adoption of biologics, targeted immunotherapies, and personalized medicine approaches, alongside expanding healthcare access in emerging economies. Auto-Immune Diseases Market Overview The Auto-Immune Diseases Market e...